Physician profile
Michael Drabkin
NPI 1992048391
$17,442.98
in general payments reported to CMS, 2019-2025
13 companies · $230 in 2025
The $230 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.66 · 2022: $6,741 · 2023: $7,571 · 2024: $2,877 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,580 · Food and Beverage: $1,022 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,580.00 |
| Food and Beverage | $1,022.37 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $13,780.00 | 2022-2024 | Certus 140 |
| Terumo Medical Corporation | $2,506.52 | 2022-2025 | Tr Band, Azur Cx Detachable, Angio-Seal |
| Ethicon US, LLC | $453.91 | 2021-2025 | Neuwave, Certus 140 |
| Bard Peripheral Vascular, INC. | $191.75 | 2024 | Trek |
| Janssen Biotech, INC. | $136.65 | 2022-2025 | Carvykti, Rybrevant |
| Merit Medical Systems INC | $108.96 | 2024-2025 | Embosphere Microspheres, Resolve Drainage Catheters |
| Astrazeneca Pharmaceuticals LP | $74.99 | 2023 | |
| Penumbra, INC. | $53.79 | 2023 | Ruby Coil, Pod |
| Idorsia Pharmaceuticals US INC | $35.00 | 2023 | Quviviq |
| Medtronic, INC. | $32.16 | 2021-2023 | Kyphon Express II Kyphopak Tray |
| Profound Medical Corp. | $31.29 | 2025 | Tulsa-Pro |
| Genzyme Corporation | $20.40 | 2022 | |
| Angiodynamics, INC. | $17.56 | 2025 | Smart Port Ct |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Drabkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.